Modulation of frequency and duration of repetitive magnetic stimulation affects catecholamine levels and tyrosine hydroxylase activity in human neuroblastoma cells: Implication for the antidepressant effect of rTMS

International Journal of Neuropsychopharmacology

Volumn 6, Issue 3, 2003, Pages 233-241

  Shaul, Uri ^a   Ben Shachar, Dorit ^a   Karry, Rachel ^a   Klein, Ehud ^a  

^a RAMBAM MEDICAL CENTER   (Israel)

Author keywords

Frequency and duration; Human neuroblastoma SH SY5Y cells; Magnetic stimulation; Noradrenaline (NE); RTMS; Tyrosine hydroxylase (TH)

Indexed keywords

CATECHOLAMINE; DOPAMINE; LEVODOPA; MONOAMINE; NORADRENALIN; TYROSINE 3 MONOOXYGENASE;

ARTICLE; BRAIN CORTEX; CATECHOLAMINE METABOLISM; CELL CULTURE; CONTROLLED STUDY; DOPAMINE RELEASE; ENZYME ACTIVITY; HUMAN; HUMAN CELL; MAGNETIC FIELD; MAJOR DEPRESSION; NEUROBLASTOMA CELL; NORADRENALIN RELEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; TISSUE CULTURE; TRANSCRANIAL MAGNETIC STIMULATION;

BLOTTING, WESTERN; BRAIN NEOPLASMS; CATECHOLAMINES; CELL LINE, TUMOR; CELL SURVIVAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DEPRESSION; ELECTROMAGNETIC FIELDS; HUMANS; NERVE TISSUE PROTEINS; NEUROBLASTOMA; TYROSINE 3-MONOOXYGENASE;

EID: 0141996415     PISSN: 14611457     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1461145703003493     Document Type: Article

References (62)

1. Baker AT (1991). An introduction to the basic principles of magnetic nerve stimulation. Journal of Clinical Neurophysiology 8, 26-37.
2. Baker AT, Jalinous R, Freeston H (1985). Non-invasive stimulation of the human motor cortex. Lancet 1, 1106-1107.
3. Basset CAL, Pawluk RJ, Pilla AA (1974). Augmentation of bone repair by inductively-coupled electromagnetic fields. Science 184, 575-577.
4. Ben-Shachar D, Belmaker RH, Grisaru N, Klein E (1997a). Transcranial magnetic stimulation induces alterations in brain monoamines. Journal of Neural Transmission 104, 191-197.
5. 2 receptor characteristics in rat brain. Brain Research 816, 78-83.
6. Ben-Shachar D, Klein E, Tabak A, Finberg JPM (1997b). Effect of single and repeated ministration of fluvoxamine on noradrenaline release in rat brain. European Journal of Pharmacology 332, 237-241.
7. Brady LS, Lynn AB, Glowa JR, Le DQ, Herkenham M (1994). Repeated electroconvulsive shock produces long-lasting increases in messenger RNA expression of corticotropin-releasing hormone and tyrosine hydroxylase in rat brain. Therapeutic implications. Journal of Clinical Investigation 94, 1263-1268.
8. Chen R, Classen J, Gerloff C (1997). Depression of motor cortex excitability by low-frequency transcranial magnetic stimulation. Neurology 48, 1398-1403.
9. Costa E, Guidotti A, Zivkovic B (1974). Short- and long-term regulation of tyrosine hydroxylase. Advances in Biochemistry and Psychopharmacology 12, 161-175.
10. Eichwald C, Walleczek J (1996). Model for magnetic field effects on radical pair recombination in enzyme kinetics. Biophysical Journal 71, 623-631.
11. Feinsod M, Kreinin B, Chistyakov A, Klein E (1998). Preliminary evidence for a beneficial effect of low frequency, repetitive transcranial magnetic stimulation in patients with major depression and schizophrenia. Depression and Anxiety 7, 65-68.
12. Fleischman A, Sternheim A, Etgen AM, Li C, Grisaru N, Belmaker RH (1996). Transcranial magnetic stimulation downregulates beta-adrenoreceptors in rat cortex. Journal of Neural Transmission 103, 1361-1356.
13. Fujiki M, Steward O (1997). High frequency transcranial magnetic stimulation mimics the effect of ECS in upregulating astroglia gene expression in the murine CNS. Brain Research and Molecular Brain Research 44, 301-308.
14. Gates JR (1995). Transcranial magnetic stimulation. Neuroimaging Clinics of North America 5, 711-720.
15. George MS, Nahas Z, Molloy M, Speer AM, Oliver NC, Li X, Arana GW, Risch SC, Ballenger JC (2000). Controlled trial of daily left prefrontal cortex TMS for treating depression. Biological Psychiatry 48, 962-970.
16. George MS, Wassermann EM, Williams WA, Callahan A, Ketter TA, Basser P, Hallett M, Post RM (1995). Daily repetitive transcranial magnetic stimulation improves mood in depression. NeuroReport 6, 1853-1856.
17. George MS, Wassermann EM, Williams WA, Steppel J, Pascual-Leone A, Basser P, Hallett M, Post RM (1996). Changes in mood and hormone levels after rapid-rate transcranial magnetic stimulation (rTMS) of the prefrontal cortex. Journal of Neuropsychiatry and Clinical Neuroscience 8, 172-180.
18. Glue P, Costello MJ, Pert A, Mele A, Nutt DJ (1990). Regional neurotransmitter responses after acute and chronic electroconvulsive shock. Psychopharmacology 100, 60-65.
19. Grisaru N, Yaroslavsky U, Abarbanel J, Lamberg T, Belmaker RH (1994). Transcranial magnetic stimulation in depression and schizophrenia. European Neuropsychopharmacology 4, 287-288.
20. Grunhaus L, Dannon P, Schrieber S, Dolberg OH, Amiaz R, Ziv R, Lefkifker E (2000). Repetitive transcranial magnetic stimulation is as effective as electroconvulsive therapy in the treatment of nondelusional major depressive disorder: an open study. Biological Psychiatry 47, 314-324.
21. Gur E, Lerer B, Dremencov E, Newman ME (2000). Chronic repetitive transctanial magnetic stimulation induces subsensitivity of presynaptic serotonergic autoreceptor activity in rat brain. NeuroReport 11, 2925-2929.
22. Hallett M (2000). Transcranial magnetic stimulation and the human brain. Nature 406, 147-150.
23. Haycock JW, Wakade AR (1992). Activation and multiple-site phosphorylation of tyrosine hydroxylase in perfused rat adrenal glands. Journal of Neurochemistry 58, 57-64.
24. Heinemann U, Schmitz D, Eder C, Gloveli T (2000). Properties of entorhinal cortex projection cells to the hippocampal formation. Annals of the New York Academy of Science 911, 112-126.
25. Hunter LW, Rorie DK, Tyce GM (1993). Inhibition of aromatic L-amino acid decarboxylase under physiological conditions: optimization of 3-hydroxybenzylhydrazine concentration to prevent concurrent inhibition of monoamine oxidase. Biochemical Pharmacology 45, 1363-1366.
26. Icard-Liepkalns C, Berrard S, Faucon Biguet N, Lebourdelles B, Ravassard P, Robert JJ, Mallet J (1993). Tyrosine hydroxylase regulation in neurotransmission and neuroplasticity. Journal of Physiology (Paris) 87, 153-157.
27. Ito H, Basset CAL (1983). Effect of weak, pulsing elecomagnetic fields on neuronal regeneration in the rat. Clinical Orthopaedics and Related Research 181, 283-290.
28. Ji RR, Schlapfer TE, Aizenman CD, Epstein CM, Qui D, Huang JC, Rupp F (1998). Repetitive transcranial magnetic stimulation activates specific regions in rat brain. Proceedings of the National Academy of Scinces USA 95, 15635-15640.
29. Kimbrell TA, Little JT, Dunn RT, Frye MA, Greenberg BD, Wasserman EM, Repella JD, Danielson AL, Willis MW, Benson BE, Speer AM, Osuch E, George MS, Post RM (1999). Frequency dependence of antidepressant response to left prefrontal repetitive transcranial magnetic stimulation (rTMS) as a function of baseline cerebral glucose metabolism. Biological Psychiatry 46, 1603-1613.
30. Kirkwood A, Bear MF (1995). Elementary forms of synaptic plasticity in the visual cortex. Biological Research 28, 73-80.
31. Klein E, Kreinin I, Chistyakov A, Koren D, Metz L, Marmur S, Ben-Shachar D, Feinsod M (1999). Therapeutic efficacy of right prefrontal slow repetitive transcranial magnetic stimulation in major depression. Archives of General Psychiatry 56, 315-320.
32. Klein E, Chistyakov AV, Kaplan B, Rubichek O, Koren D, Hafner H, Geter N, Feinsod M (2002). Differential effects of laterality and frequency of rTMS on clinical outcome and excitability in patients with major depression. Abstract presented at the Fifth Meeting of the International Society for Transcranial Stimulation, Philadelphia.
33. 1 and MNDA binding sites by a single rapid transcranial magnetic stimulation procedure in rats. Brain Research 826, 309-312.
34. Koubi D, Bezin L, Cottet-Emard JM, Gharib A, Bobillier P, Sarda N (2001). Regulation of expression and enzymatic activities of tyrosine and tryptophan hydroxylases in rat brain after acute electroconvulsive shock. Brain Research 905, 161-170.
35. Krings T, Reinges MH, Foltys H, Cosgrove GR, Thron A (2001). Multimodality neuroimaging: research and clinical applications. Neurology and Clinical Neurophysiology 2001, 2-11.
36. Lednev VV (1991). Possible mechanism for the influence of weak magnetic field on biological systems. Bioelectromagnetics 12, 51-75.
37. Leviel V, Fayada C, Guibert B, Chaminade M, Machek G, Mallet J, Biguet NF (1990). Short- and long-term alterations of gene expression in limbic structures by repeated electroconvulsive-induced seizures. Journal of Neurochemistry 54, 899-904.
38. Liboff AR (1994). The electromagnetic field as a biological variable. In: Ferry AH (Ed.), On the Nature of Electromagnetic Field Interaction with Biological Systems (pp. 73-82). Austin: R. G. Landes.
39. Lisanby SH, Belmaker RH (2000). Animal models of the mechanisms of action of repetitive transcranial magnetic stimulation (rTMS): comparisons with electroconvulsive shock (ECS). Depression and Anxiety 12, 178-187.
40. Macias MY, Battocletti JH, Sutton CH, Pintar FA, Maiman DJ (2000). Directed and enhanced neurite growth with pulsed magnetic field stimulation. Bioelectromagnetics 21, 272-286.
41. Masserano JM, Weiner N (1983). Tyrosine hydroxylase regulation in the central nervous system. Molecular and Cellular Biochemistry 53, 129-152.
42. Massot O, Grimaldi B, Bailly JM, Kochanek M, Deschamps F, Lambrozo J, Fillion G (2000). Magnetic field desensitizes 5-HT(1B) receptor in brain: pharmacological and functional studies. Brain Research 858, 143-150.
43. Pascual-Leone A, Valls-Sole J, Wassermann EM, Hallett M (1994). Responses to rapid-rate transcranial magnetic stimulation of the human motor cortex. Brain 117, 847-858.
44. Pascual-Leone A, Rubio B, Pallardo F, Catala MD (1996a). Rapid-rate transcranial magnetic stimulation of left dorsolateral prefrontal cortex in drug-resistant depression. Lancet 348, 959.
45. Pascual-Leone A, Catala MD, Pascual-Leone Pascual A (1996b). Lateralized effect of rapid-rate transcranial magnetic stimulation of the prefrontal cortex on mood. Neurology 46, 449-502.
46. Paus T, Jech R, Thompson CJ, Comeau R, Peters T, Evans AC (1997). Transcranial magnetic stimulanion during positron emission tomography: a new method for studying connectivity of the human cerebral cortex. Journal of Neuroscience 17, 3178-3184.
47. Pieribone VA, Shupliakov O, Brodin L, Hilfiker-Rothenfluh S, Czernik AJ, Greengard P (1995). Distinct pools of synaptic vesicles in neurotransmitter release. Nature 375, 493-497.
48. Plaznik A, Stfanski R, Palejko W, Bidzinski A, Kostowski W, Jessa M, Nazar M (1994). Antidepresant treatment and limbic serotonergic mechanisms regulating rat locomotor activity. Pharmacology, Biochemistry, and Behavior 48, 315-325.
49. Rice ME, Cragg SJ, Greenfield SA (1997). Characteristics of electrically evoked somatodendritic dopamine release in substantia nigra and ventral tegmental area in vitro. Journal of Neurophysiology 77, 853-862.
50. Sacchetti G, Bernini M, Bianchetti A, Parini S, Invernizzi RW, Samanin R (1999). Studies on the acute and chronic effects of reboxetine on extracellular noradrenaline and other monoamines in the rat brain. British Journal of Pharmacology 128, 1332-1338.
51. Sackeim HA (2000). Repetitive transcranial magnetic stimulation: what are the next steps? Biological Psychiatry 48, 959-961.
52. Salzman PM, Roth RH (1980). Poststimulation catecholamine synthesis and tyrosine hydroxylase activation in central noradrenergic neurons. II. Depolarized hippocampal slices. Journal of Pharmacology and Experimental Therapeutics 212, 74-84.
53. Shajahan PM, Glabus MF, Steele JD, Doris AB, Anderson K, Jenkins JA, Gooding PA, Ebmeier KP (2002). Left dorso-lateral repetitive transcranial magnetic stimulation affects cortical excitability and functional connectivity, but does not impair cognition in major depression. Progress in Neuropsychopharmacology and Biological Psychiatry 26, 945-954.
54. Sisken BF, Walker J, Orgel M (1993). Prospects on clinical application of electrical stimulation for nerve regeneration. Journal of Cellular Biochemistry 52, 404-409.
55. Speer AM, Kimbrell TA, Wassermann EM, Repella J, Willis MW, Herscovitch P, Post RM (2000). Opposite effects of high and low frequency rTMS on regional brain activity in depressed patients. Biological Psychiatry 48, 1133-1141.
56. Tal D, Jacobson E, Lyakhov V, Maron S (2001). Frequency tuning of input-output relation in a rat cortical neuron in-vitro. Neuroscience Letters 300, 21-24.
57. Uzdensky AB (1999). A cytologist's view of resonance mechanisms for biologic effects of ELF magnetic fields. Electro and Magnetobiology 18, 67-78.
58. Walker J, Evans JM, Resig P, Guarnieri S, Meade P, Sisken BF (1994). Enhancement of functional recovery following crush lesion to the rat sciatic nerve by exposure to PEMF. Experimental Neurology 125, 302-304.
59. Willets JM, Lambert DG, Griffiths HR (1993). Suitability of B65 and SH-SY5Y neuroblastoma cells as models for in vitro neurotoxicity testing. Biochemical Society Transactions 21, 452S.
60. Yoshida K, Higuchi H, Kamata M, Shimiz T, Hishikawa Y (1997). Dopamine releasing response in rat striatum to single and repeated electroconvulsive shock treatment. Progress in Neuropsychopharmacology and Biological Psychiatry 21, 707-715.
61. Zis AP, Nomikos GG, Brown EE, Damsma G, Fibiger HC (1992). Neurochemical effects of electrically and chemically induced seizures: an in vivo microdialysis study in the rat hippocampus. Neuropsychopharmacology 7, 189-195.
62. Zyss T, Mamczarz J, Vetulani J (1999). The influence of rapid-rate transcranial magnetic stimulation (rTMS) parameters on rTMS effects in Porsolt's forced swimming test. International Journal of Neuropsychopharmacology 2, 31-34.